Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AMPHthis companyAmphastar Pharmaceuticals, Inc.	$28.90	12.75×	1.59×	1.74×	8.18×	241.3%	49.5%	19.5%	13.6%	12.4%	7.5%	9.7%	0.83×	2.29×	5.51×	4.02×	0.0%	6	2.19	4	A-
AMRXAmneal Pharmaceuticals, Inc.	$20.94	54.78×	-55.77×	1.31×	10.56×	-33.0%	37.6%	14.0%	2.4%	-101.8%	13.8%	6.8%	-38.65×	4.02×	1.75×	2.17×	0.0%	7	2.58	3	B
AYTUAytu BioPharma, Inc.	$1.89	-1.85×	0.75×	0.46×	-4.17×	-322.8%	64.0%	-14.4%	-24.8%	-40.4%	-14.2%	12.3%	0.51×	1.87×	4.39×	1.13×	0.0%	4	-4.22	2	C
COLLCollegium Pharmaceutical, Inc.	$24.69	23.38×	4.87×	1.88×	5.38×	2688.6%	59.3%	24.0%	8.1%	20.8%	10.2%	22.3%	3.12×	1.72×	2.27×	1.57×	0.0%	5	0.95	3	B-
ETONEton Pharmaceuticals, Inc.	$59.24	-99.47×	17.4×	5.69×	107.83×	-174.2%	53.5%	0.1%	-5.8%	-17.6%	0.1%	2.2%	1.19×	1.19×	0.02×	1.57×	0.0%	7	12.98	3	B
VTRSViatris Inc.	$20.18	-4.15×	0.99×	1.02×	-70.63×	6.4%	35.1%	-18.6%	-24.6%	-23.9%	-7.9%	13.3%	1×	-33.77×	-5.65×	1.3×	3.9%	7	1.15	2	C
Peer median	—	-1.85×	0.99×	1.31×	5.38×	-33.0%	53.5%	0.1%	-5.8%	-23.9%	0.1%	12.3%	1×	1.72×	1.75×	1.57×	0.0%	7	1.15	3	—